Late intestinal complications in minimally invasive total gastrectomy for gastric cancer

The risk factor of late intestinal complications in minimally invasive total gastrectomy for gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN67352603

Enrollment

302

Registered

2024-03-19

Start date

2021-01-01

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of late intestinal complications in patients who underwent minimally invasive total gastrectomy for gastric cancer. Surgery

Interventions

The procedure comprises four major steps, typified by the closure of the mesentery and diaphragm crus, and fixation and linearization around the anastomotic site of esophagojejunostomy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients between January 2009 and December 2019. 2. Patients underwent total gastrectomy for gastric cancer at our division.

Exclusion criteria

Exclusion criteria: 1. Open gastrectomy 2. Clinical or pathological stage IV 3. Remnant gastric cancer 4. Palliative surgery 5. EGJ cancer 6. Observation period < 90 days 7. Use of circular stapler

Design outcomes

Primary

Measure	Time frame
The incidence of complications within 3 years after surgery measured using data collected from medical records at one time point	—

Secondary

Measure	Time frame
The following secondary outcome variables will be measured using data collected from medical records at one time point: 1. Clinicopathological characteristics 2. Short-term surgical outcomes: 2.1. Operative time 2.2. Surgeon console time 2.3. Estimated blood loss 2.4. Number of dissected lymph nodes 2.5. Rates of local and systemic complications 2.6. Mortality rate 2.7. Length of postoperative hospitalization 2.8. Severity of reflux esophagitis at preoperative year (POY) 1 2.9. Body weight loss rate at POY 1 3. Long-term survival outcomes: 3.1. 3-year overall survival (OS) 3.2. 3-year relapse-free survival (RFS)	—

Measure

Time frame

The following secondary outcome variables will be measured using data collected from medical records at one time point: 1. Clinicopathological characteristics 2. Short-term surgical outcomes: 2.1. Operative time 2.2. Surgeon console time 2.3. Estimated blood loss 2.4. Number of dissected lymph nodes 2.5. Rates of local and systemic complications 2.6. Mortality rate 2.7. Length of postoperative hospitalization 2.8. Severity of reflux esophagitis at preoperative year (POY) 1 2.9. Body weight loss rate at POY 1 3. Long-term survival outcomes: 3.1. 3-year overall survival (OS) 3.2. 3-year relapse-free survival (RFS)

—

Countries

Japan

Contacts

Public ContactSusumu Shibasaki

susumushi48@mist.ocn.ne.jp+81562939254

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026